Results 121 to 130 of about 150,878 (257)

Anti-latency agents to purge HIV reservoirs

open access: yesRetrovirology, 2012
Moreno Santiago
doaj   +1 more source

Why Evidence Is Not Enough: Power, Politics, and a Strategy Shift for Public Health

open access: yesThe Milbank Quarterly, EarlyView.
Policy Points Public health has lost political influence because of a mismatch between the forms of power primarily deployed in this field—knowledge and moral authority—and the forms of power that currently shape societal rules and health outcomes—economic, political, ideological, and physical.
JONATHAN C. HELLER
wiley   +1 more source

Stigma as a Social Determinant of Health: A Policy Classification Framework and Call to Action

open access: yesThe Milbank Quarterly, EarlyView.
Policy Points Stigma functions as a social determinant of health (SDOH), producing population health inequities through resource deprivation, social exclusion, constrained health care, physiological stress, and diminished agency—yet it lacks formal SDOH classification.
LISA CARTER‐BAWA
wiley   +1 more source

EMBODIED DATA/SUBALTERN DATAFICATION: Reimagining the Data‐Based City Through Quantified Lived Experience

open access: yesInternational Journal of Urban and Regional Research, EarlyView.
Abstract This article outlines possibilities for counter configurations of data‐based urbanisms, whereby data practices, rather than reproducing logics of urban entrepreneurialism and smart‐city governance, are made from within urban peripheral territories.
Andrés Luque‐Ayala, Rodrigo Firmino
wiley   +1 more source

TWO CONCEPTS OF POLARIZATION: Urban–National Tension and its Effects on the Liberal Trajectory of Cities

open access: yesInternational Journal of Urban and Regional Research, EarlyView.
Abstract This study examines how urban–national polarization shapes how progressive cities exercise local autonomy. It introduces a new framework for assessing polarization within specific policy domains, distinguishing between ideological and pragmatic polarization.
Harel Nachmany, Tal Alster, Nufar Avni
wiley   +1 more source

Antiretroviral Therapy-Associated Weight Gain in Mexico, a Country Prone to Comorbidities [PDF]

open access: yesInternational Journal of Health Policy and Management
Andrés Tapia-Maltos   +1 more
doaj   +1 more source

The Impact of Common Medications on Male Fertility: An Updated Systematic Review

open access: yesAndrology, EarlyView.
ABSTRACT Background Compared with those of cytotoxic treatments, the potential effects of common medications on the fertility of men trying to conceive currently or planning to conceive in the future are less well described. The use of common medications may modify the gonadotropic axis, spermatogenesis, and epididymal maturation or alter male ...
Lina Jebli   +7 more
wiley   +1 more source

Navigating Ethical Review Processes in Conflict‐Affected, Authoritarian Contexts: A Case Study of Myanmar's Interim Ethics Review Board (IERB)

open access: yesAsia Pacific Viewpoint, EarlyView.
ABSTRACT This article examines the formation and operation of Myanmar's Interim Ethics Review Board (IERB), which was established in November 2023 by displaced academics involved in the Civil Disobedience Movement against the 2021 military coup. Operating within a highly repressive, conflict‐ridden environment, the IERB exemplifies a locally‐led and ...
Phyu Phyu Thin Zaw   +3 more
wiley   +1 more source

SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma

open access: yesBritish Journal of Haematology, EarlyView.
Summary The randomized phase II SAKK 35/14 trial, conducted by the Swiss Group for Clinical Cancer Research (SAKK) and the Nordic Lymphoma Group (NLG), compared efficacy and safety of rituximab (375 mg/m2 intravenously for 4 weeks followed by maintenance every 2 months for 24 months) plus placebo (arm A) versus the same schedule of rituximab plus ...
Maria Cristina Pirosa   +25 more
wiley   +1 more source

Cancer pain: current practice and emerging targets

open access: yesBritish Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy